PARP-1 activity was found to be significantly upregulated in various animal models of pathological cardiac hypertrophy [21, 46], and PARP-1 deficient mice significantly attenuated AngII-mediated cardiac hypertrophy [41]. The gene discussed is AGT; the disease is cardiac hypertrophy.